In the face of challenging new standards, evolving payment systems, and shifting regulatory demands, oncology providers may wonder how they'll manage to achieve innovative, high-quality cancer care.
But the recent changes in the healthcare system create exactly the type of disruptive environment that fosters the most innovation, said Whitney Johnson, keynote speaker, in her session "Dare to Disrupt: Innovate from the Inside.” A central theme across many sessions at the 30th ACCC National Oncology Conference was how to harness the synergy between disruption and innovation.
From a panel discussion on "Innovation: Value, Quality, and Technology" to presentations by the 2013 ACCC Innovator Award winners and a town hall discussion on new payment models, sessions spotlighted the innovative ideas emerging from today's disruptive oncology landscape.
The ten 2013 ACCC Innovator Award Winner sessions offered during the conference provided attendees with patient-centered, data-driven, replicable solutions to real-world challenges in the delivery of quality cancer care.
ACCC CLINICAL RESEARCH AWARD
Paul F. Engstrom, MD, was presented with the ACCC Clinical Research Award on Friday, Oct. 4. In his acceptance remarks Dr. Engstrom noted ACCC’s long history of support for the role of community oncology in clinical research. “I believe clinical cancer research is only relevant when it involves community patients and their oncologists,” he said. Dr. Engstrom was honored for his work in advocating for cancer prevention and screening programs in research through the U.S. and around the globe.
SHOWCASE SESSIONS SPARK NEW IDEAS
Added this year was a Showcase Session featuring 10 ACCC-member programs presenting quick-takes on strategies to improve patient care. Topics ranged from survivorship services to navigation programs, to a program to improve access for underserved populations, and more.